Efficacy of nasal high flow therapy for respiratory management in patients after sagittal splitting ramus osteotomy research

Efficacy of nasal high flow therapy for respiratory management in patients after sagittal splitting ramus osteotomy research - Efficacy of nasal high flow therapy for respiratory management in patients after sagittal splitting ramus osteotomy research

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000041116

Enrollment

Registered

2020-10-01

Start date

2021-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

after sagittal splitting ramus osteotomy

Interventions

nasal high flow therapy From 0 hours after returning to the ward until waking up the next morning

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing sagittal splitting ramus osteotomy for jaw deformity

Exclusion criteria

Exclusion criteria: Patients with respiratory diseases Patients with American Society of Anesthesiologists systemic classification of 3 or higher Patients who cannot consent to post-operative arterial line implantation and percutaneous monitoring on the ward Patients with suspected COVID-19 infection

Design outcomes

Primary

Measure	Time frame
Continuous measurements of partial pressure of carbon dioxide and oxygen by arterial blood gas analysis and transcutaneous gas monitor from 0 hours after return to the ward to the time of waking up the next morning	—

Countries

Japan

Contacts

Public ContactYukiko Baba

Tokyo medical and dental university graduate school of medical and dental sciences dental anesthesiology and olofacial pain management

yukianph@tmd.ac.jp0358035549

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026